Skip to content
Prandin

Prandin

Repaglinide

Repaglinide tablets for type 2 diabetes. It triggers a quick burst of insulin after meals rather than a steady supply throughout the day.

All strengths and pack prices
StrengthPackPricePer unit
0.5mg30 tablets$80.00$2.67
0.5mg60 tablets$139.00$2.32
0.5mg90 tablets$194.00$2.16
0.5mg120 tablets$241.00$2.01
0.5mg180 tablets$330.00$1.83
0.5mg360 tablets$601.00$1.67
1mg30 tablets$93.00$3.10
1mg60 tablets$166.00$2.77
1mg90 tablets$236.00$2.62
1mg120 tablets$307.00$2.56
1mg180 tablets$451.00$2.51
1mg270 tablets$666.00$2.47
1mg360 tablets$881.00$2.45
2mg30 tablets$104.00$3.47
2mg60 tablets$194.00$3.23
2mg90 tablets$285.00$3.17
2mg120 tablets$376.00$3.13
2mg180 tablets$558.00$3.10
2mg270 tablets$828.00$3.07
2mg360 tablets$1105.00$3.07
Active ingredient
Repaglinide
Route
Oral use
Form
Tablet
Strengths
0.5mg · 1mg · 2mg

This listing uses Prandin as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.

Prescription and consultation requirements for Prandin vary by destination and are determined by the fulfilment partner.

Prandin details

Alternative names
repaglinide
Therapeutic class
Meglitinide
Pharmacological class
Antidiabetic
Minor side effects
nausea; headache; indigestion
Moderate side effects
hypoglycaemia; weight gain; diarrhoea
Serious side effects
severe hypoglycaemia, requires immediate medical attention
Dosage forms
Tablet
Administration route
Oral use
Originator
Novo Nordisk
Onset time
30 minutes
Duration
3–4 hours
Storage instructions
Store below 25°C.
Drug interactions
Gemfibrozil; Ketoconazole; Rifampin
Age restrictions
Approved for adults.
Contraindications

diabetic ketoacidosis; type 1 diabetes; concurrent gemfibrozil use; severe liver disease

Patient summary

Repaglinide tablets for type 2 diabetes. It triggers a quick burst of insulin after meals rather than a steady supply throughout the day.

Mechanism of action

Stimulates rapid insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels.

Pregnancy and breastfeeding

Pregnancy: Use if clearly indicated. Insulin preferred in pregnancy. Breastfeeding: Not recommended.

What you will receive

Prandin is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.

  • The supplied product is a generic equivalent containing Repaglinide, not the originator brand shown as the reference.
  • The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
  • Check the final product details at checkout before confirming an order.

How we compare medicine brands and generics